• Inherited Retinal Diseases
  • Retina Technology
  • RVO
  • Geographic Atrophy
  • Uveitis
  • Ophthalmology
  • Retinal Surgery
  • Imaging
  • AMD
  • Diabetic Macular Edema
  • Diabetic Retinopathy

Latest News

Opus Genetics completes dosing of the first cohort in Phase 1/2 trial evaluating the subretinal delivery of OPGx-LCA5
Opus Genetics completes dosing of the first cohort in Phase 1/2 trial evaluating the subretinal delivery of OPGx-LCA5

March 27th 2024

In this cohort of 3 adult patients, there was positive safety and efficacy data.

Phase Ib/IIa trial of EXN407 eye drops from Exonate demonstrates safety and tolerability
Phase Ib/IIa trial of EXN407 eye drops from Exonate demonstrates safety and tolerability

March 27th 2024

Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa
Nanoscope Therapeutics lead candidate MCO-010 meets endpoints in RESTORE trial for retinitis pigmentosa

March 26th 2024

Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration

March 26th 2024

Study shows minocycline has no benefit in slowing geographic atrophy expansion in patients with dry age-related macular degeneration
Study shows minocycline has no benefit in slowing geographic atrophy expansion in patients with dry age-related macular degeneration

March 26th 2024

Latest Videos
Continuing Medical Education

Latest News

© 2024 MJH Life Sciences

All rights reserved.